Tandem Duplication of KIT Exon 11 Influences the Proteome of Canine Mast Cell Tumours

Journal of Comparative Pathology

Volumn 148, Issue 4, 2013, Pages 318-322

  Schlieben, P ^a   Meyer, A ^a   Weise, C ^a   Bondzio, A ^a   Gruber, A D ^a   Klopfleisch, R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Dog; KIT; Mast cell tumours; Proteomic analysis

Indexed keywords

ACSBG4 PROTEIN; ACTB PROTEIN; ACTR2 PROTEIN; ALOX15 PROTEIN; ARHGDIA PROTEIN; CAPPA1 PROTEIN; PLASMA PROTEIN; PROTEOME; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; CELL STRUCTURE; CYTOSKELETON; EXON; GENE DUPLICATION; GENE MUTATION; LIPID METABOLISM; MASTOCYTOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; DOG DISEASES; DOGS; EXONS; MAST CELLS; MAST-CELL SARCOMA; PROTEOME; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CANIS FAMILIARIS;

EID: 84876816505     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2012.07.006     Document Type: Article

References (34)

1. Altschuler G.M., Willison K.R. Development of free-energy-based models for chaperonin containing TCP-1 mediated folding of actin. Journal of the Royal Society Interface 2008, 5:1391-1408.
2. Butler B., Cooper J.A. Distinct roles for the actin nucleators Arp2/3 and hDia1 during NK-mediated cytotoxicity. Current Biology 2009, 19:1886-1896.
3. Carnell M.J., Insall R.H. Actin on disease - studying the pathobiology of cell motility using Dictyostelium discoideum. Seminars in Cell and Developmental Biology 2011, 22:82-88.
4. Downing S., Chien M.B., Kass P.H., Moore P.E., London C.A. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. American Journal of Veterinary Research 2002, 63:1718-1723.
5. Galvao E.R., Martins L.M., Ibiapina J.O., Andrade H.M., Monte S.J. Breast cancer proteomics: a review for clinicians. Journal of Cancer Research and Clinical Oncology 2011, 137:915-925.
6. Jones C.L., Grahn R.A., Chien M.B., Lyons L.A., London C.A. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. Journal of Veterinary Diagnostic Investigation 2004, 16:95-100.
7. Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. Journal of Clinical Investigation 2011, 121:2000-2012.
8. Kiupel M., Webster J.D., Bailey K.L., Best S., Delay J., et al. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Veterinary Pathology 2011, 48:147-155.
9. Klopfleisch R., Klose P., Weise C., Bondzio A., Multhaup G., et al. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. Journal of Proteome Research 2010, 9:6380-6391.
10. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 2010, 10:618.
11. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. Veterinary Journal 2010, 190:236-243.
12. Klopfleisch R., Meyer A., Schlieben P., Weise C., Bondzio A., et al. Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes. BMC Veterinary Research 2012, 8:96.
13. Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., et al. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?. Journal of Proteome Research 2011, 10:4405-4415.
14. Letard S., Yang Y., Hanssens K., Palmerini F., Leventhal P.S., et al. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Molecular Cancer Research 2008, 6:1137-1145.
15. London C.A., Galli S.J., Yuuki T., Hu Z.Q., Helfand S.C., et al. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Experimental Haematology 1999, 27:689-697.
16. London C.A., Kisseberth W.C., Galli S.J., Geissler E.N., Helfand S.C. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. Journal Comparative Pathology 1996, 115:399-414.
17. Masson K., Ronnstrand L. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signalling 2009, 21:1717-1726.
18. Meyer A, Gruber AD, Klopfleisch R. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells. Veterinary Pathology. doi:10.1177/0300985812439215.
19. Nomura H., Uzawa K., Ishigami T., Kouzu Y., Koike H., et al. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 2008, 8:39.
20. Nurmio M., Kallio J., Toppari J., Jahnukainen K. Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis. Reproductive Toxicology 2008, 25:442-446.
21. Patnaik A.K., Ehler W.J., MacEwen E.G. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984, 21:469-474.
22. Pittoni P., Piconese S., Tripodo C., Colombo M.P. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene 2011, 30:757-769.
23. Pryer N.K., Lee L.B., Zadovaskaya R., Yu X., Sukbuntherng J., et al. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Clinical Cancer Research 2003, 9:5729-5734.
24. Schlieben P, Meyer A, Weise C, Bondzio A, Einspanier R et al. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours. Veterinary Journal. http://dx.doi.org/10.1016/j.tvjl.2012.04.002.
25. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Analytical Chemistry 1996, 68:850-858.
26. Skawran B., Steinemann D., Becker T., Buurman R., Flik J., et al. Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma. Modern Pathology 2008, 21:1479-1489.
27. Sun D., Zhou M., Kowolik C.M., Trisal V., Huang Q., et al. Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma. Melanoma Research 2011, 21:335-343.
28. Webster J.D., Yuzbasiyan-Gurkan V., Kaneene J.B., Miller R., Resau J.H., et al. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 2006, 8:104-111.
29. Webster J.D., Yuzbasiyan-Gurkan V., Miller R.A., Kaneene J.B., Kiupel M. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Veterinary Pathology 2007, 44:298-308.
30. Westermeier R., Scheibe B. Difference gel electrophoresis based on lys/cys tagging. Methods in Molecular Biology 2008, 424:73-85.
31. Yarar D., D'Alessio J.A., Jeng R.L., Welch M.D. Motility determinants in WASP family proteins. Molecular Biology of the Cell 2002, 13:4045-4059.
32. Yokotsuka M., Iwaya K., Saito T., Pandiella A., Tsuboi R., et al. Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer. Breast Cancer Research and Treatment 2011, 126:311-318.
33. Zemke D., Yamini B., Yuzbasiyan-Gurkan V. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Veterinary Pathology 2002, 39:529-535.
34. Zhang R., Zhou L., Li Q., Liu J., Yao W., et al. Up-regulation of two actin-associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia. American Journal of Respiratory Cellular and Molecular Biology 2009, 41:467-475.